SCHEMBL26502890

SCHEMBL26502890

CC(C)(C)C1CCN(C(=O)CO)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ EPHX2 P34913 1/20 0.38
▸ HSD11B1 P28845 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ JAK2 O60674 2/20 0.32
▸ JAK3 P52333 2/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ PKN2 Q16513 1/20 0.32
▸ AURKB Q96GD4 1/20 0.32
▸ LYPLA1 O75608 1/20 0.32
▸ LYPLA2 O95372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20464225 0.89 ALDH1A1 (0.44) CYP2D6KCNH2HRH3HSD11B1ALDH1A1
SCHEMBL12384632 0.89 CYP2D6 (0.50) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL19703906 0.85 HSD11B1 (0.45) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL25034509 0.84 CHRNB2 (0.35) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL14592895 0.84 CYP2D6 (0.42) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL24491596 0.82 CYP2D6 (0.41) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL12125541 0.80 CYP2D6 (0.40) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL12384400 0.80 CYP2D6 (0.40) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL15448194 0.79 CYP2D6 (0.47) CYP2D6KCNH2HRH3EPHX2HSD11B1
SCHEMBL12384517 0.79 EPHX2 (0.53) CYP2D6KCNH2HRH3EPHX2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230131535-A1 ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS KCNJ2, KCNA3, KCNK3 CYP2D6 670/4885KCNH2 7/4885HRH3 598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback